ACTRIMS Investor Call
Sanofi was pleased to invite investors and analysts to participate in a live webcast discussing tolebrutinib data presented during the ACTRIMS scientific program (February 24-26, 2022).
(16h00 CET / 10:00am EST)
Global Head of Development,
Global Franchise Head, Neurology
Therapeutic Area Head, Multiple Sclerosis
Professor and Research Chair of the MS Society of Canada at the University of British
Global Project Head, Neurology